Patritumab (Anti-ERBB3 / HER3)

製品コード：A2506         Batch: A250602

印刷

Patritumab (Anti-ERBB3 / HER3) is a neutralizing monoclonal antibody targeting ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors. MW: 145.5 KD.

製品説明

CAS No. 1262787-83-6
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 13.58mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。